Tg Therapeutics (TGTX) Receivables - Net (2014 - 2026)
Tg Therapeutics' Receivables - Net was $401.57 million in Q2 2026, up 73.5% from $231.52 million a year earlier and up 2.4% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Receivables - Net (2014 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at Tg Therapeutics came in at $305.63 million, up 136.6% from FY2024.
- Receivables - Net shows a four-year compound annual growth rate of 285.1% (FY2021 to FY2025).
- In earlier years, Receivables - Net was $129.19 million in FY2024 (+152.8%), $51.09 million in FY2023 and $1.39 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Receivables - Net in data going back to Q1 2014.
- Compared with a year earlier, Receivables - Net has increased for ten straight quarters, with growth averaging 145.3% over the last eight quarters.
- The best year-over-year quarter for Receivables - Net over five years was Q1 2023 (growth of 854.9%); the worst was Q2 2022 (a decline of 90.5%).
- Per Business Quant data, TGTX's Receivables - Net in the three quarters before Q2 2026 was $392.05 million (Q1 2026), $305.63 million (Q4 2025) and $265.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Tg Therapeutics | 8.60 Bn | 7.99 Bn | 199.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 401.57 Mn |
| Mar 31, 2026 | 392.05 Mn |
| Dec 31, 2025 | 305.63 Mn |
| Sep 30, 2025 | 265.38 Mn |
| Jun 30, 2025 | 231.52 Mn |
| Mar 31, 2025 | 190.12 Mn |
| Dec 31, 2024 | 129.19 Mn |
| Sep 30, 2024 | 115.73 Mn |
| Jun 30, 2024 | 83.61 Mn |
| Mar 31, 2024 | 64.98 Mn |
| Dec 31, 2023 | 51.09 Mn |
| Sep 30, 2023 | 39.32 Mn |
| Jun 30, 2023 | 17.48 Mn |
| Mar 31, 2023 | 8.62 Mn |
| Jun 30, 2022 | 88,000.00 |
| Mar 31, 2022 | 903,000.00 |
| Dec 31, 2021 | 1.39 Mn |
| Sep 30, 2021 | 1.38 Mn |
| Jun 30, 2021 | 931,000.00 |
| Mar 31, 2021 | 771,000.00 |
API Access
Tg Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();